Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07117136 · ClinicalTrials.gov registry record
Blinatumomab Consolidation in Real World
A clinical trial of B-Cell Acute Lymphoblastic Leukaemia, sponsored by Medical College of Wisconsin.
- Recruiting
- Registry status
- 200
- Enrollment target
- 1
- Study location
NCT07117136 is a study of B-Cell Acute Lymphoblastic Leukaemia that is actively recruiting participants, run by Medical College of Wisconsin. The registered enrollment target is 200 participants. The trial reports 1 study location across 1 state.
The verdict
NCT07117136, a study of B-Cell Acute Lymphoblastic Leukaemia, is actively recruiting participants, sponsored by Medical College of Wisconsin.
- RECRUITING
- Registry status
- 200 participants
- Enrollment target
- 1
- Study location
Study Summary
This will be a multi-center registry for patients with B-ALL. Patient data will be collected both retrospectively and prospectively. The data forms and surveys will be built and managed through REDCap, a secure web application managed by the Clinical \& Translational Science Institute.
Conditions Studied
Study Locations (1)
Wisconsin
- Medical College of Wisconsin - Milwaukee
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2025-08-28 |
| Est. Completion | 2029-05-14 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07117136
The ClinicalTrials.gov registry entry for NCT07117136 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medical College of Wisconsin, which has 447 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with B-Cell Acute Lymphoblastic Leukaemia appearing as the primary indexed condition, and to 0 interventions.
NCT07117136 reports 1 study location spanning 1 distinct geographic area - top geographies include Wisconsin.
Frequently Asked Questions
What is clinical trial NCT07117136 about?
NCT07117136 is a clinical study titled "Blinatumomab Consolidation in Real World". This will be a multi-center registry for patients with B-ALL. Patient data will be collected both retrospectively and prospectively. The data forms and surveys will be built and managed through REDCap, a secure web application managed by the Clinical \& Translational Science Institute.
What is the current status of trial NCT07117136?
This trial is currently recruiting. The enrollment target is 200 participants. The study started on 2025-08-28. Estimated completion is 2029-05-14.
What conditions does trial NCT07117136 study?
This clinical trial studies the following conditions: B-Cell Acute Lymphoblastic Leukaemia.
Who is sponsoring clinical trial NCT07117136?
This trial is sponsored by Medical College of Wisconsin, which has 447 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07117136 being conducted?
This trial has 1 study location across Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for B-Cell Acute Lymphoblastic Leukaemia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.